67289) med henblik på at undersøge bioækvivalensen af LISONORM FORTE (fast kombination af amlodipin 10 mg og lisinopril 20 mg), samtidig administration af NORVASC 10 mg (indeholdende amlodipin 10 mg) og PRINIVIL 20 mg (indeholdende lisinopril 20 mg) og LISONORM (fast kombination af amlodipin 5 mg og lisinopril 10 mg) under fastende betingelser.
Therefore, the Applicant acknowledged the limitations arising from the product selection in the initial pivotal BE study and performed a study (Protocol No 67289) to investigate bioequivalence of LISONORM FORTE (fixed-combination of amlodipine 10 mg and lisinopril 20 mg), co-administration of NORVASC 10 mg (containing amlodipine 10 mg) and PRINIVIL 20 mg (containing lisinopril 20 mg), and LISONORM (fixed-combination of amlodipine 5 mg and lisinopril 10 mg) under fasting conditions.